Systemic anti-cancer therapy delivery in the home: a service model.
Br J Nurs
; 29(10): S22-S29, 2020 May 28.
Article
em En
| MEDLINE
| ID: mdl-32463747
ABSTRACT
The Christie NHS Foundation Trust is a leader in adapting patient care in response to treatment advances and new patient-centred care/efficiency initiatives. Due to extended waiting times in cancer clinics, The Christie developed an at-home treatment service to help reduce the pressure on clinics and improve patient experience. This article provides a detailed examination of the requirements necessary to successfully develop a home service for the delivery of systemic anticancer treatment. The authors discuss the criteria used to identify suitable at-home treatments, as well as necessary resources and equipment. The success of the Christie at Home service was examined using a patient survey to assess the standard of this care. Details are given regarding the challenges of implementing a homecare service and potential future challenges. As an example, systemic treatment with eribulin as a 'Christie at Home' therapy demonstrates the practicalities of introduction of new therapies in a homecare service.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Guias de Prática Clínica como Assunto
/
Assistência Centrada no Paciente
/
Serviços de Assistência Domiciliar
/
Neoplasias
/
Antineoplásicos
Tipo de estudo:
Guideline
/
Prognostic_studies
Limite:
Humans
País como assunto:
Europa
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article